CYduct Diagnostics (CYDX) Financial Statements
CYduct Diagnostics Financial Overview
CYduct Diagnostics's market cap is currently $2.57M. The company's EPS TTM is $-0.04; its P/E ratio is -11.13; CYduct Diagnostics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 70.37K | $ 70.69K | $ 84.48K | $ 119.34K | $ 94.05K |
| Gross Profit | $ 43.85K | $ 46.79K | $ 56.59K | $ 83.40K | $ 63.51K |
| Operating Income | $ -154.88K | $ -363.22K | $ -378.91K | $ -444.65K | $ -403.55K |
| EBITDA | $ -154.88K | $ -363.22K | $ -378.91K | $ -441.25K | $ -166.99K |
| Net Income | $ -207.40K | $ -413.61K | $ -418.03K | $ -472.74K | $ -420.49K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.21K | $ 1.21K | $ 29.80K | $ 54.83K | $ 271.68K |
| Total Assets | $ 30.02K | $ 37.68K | $ 54.75K | $ 80.85K | $ 296.67K |
| Total Debt | $ 707.90K | $ 713.39K | $ 670.00K | $ 570.00K | $ 520.00K |
| Net Debt | $ 700.68K | $ 712.18K | $ 640.20K | $ 515.17K | $ 248.32K |
| Total Liabilities | $ 1.09M | $ 2.85M | $ 2.45M | $ 2.10M | $ 1.85M |
| Stockholders' Equity | $ -1.06M | $ -2.81M | $ -2.40M | $ -2.02M | $ -1.55M |
| Cash Flow | |||||
| Free Cash Flow | $ 11.50K | $ -71.98K | $ -174.83K | $ -266.85K | $ -127.73K |
| Operating Cash Flow | $ 11.49K | $ -71.98K | $ -174.83K | $ -266.85K | $ -127.73K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -191.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -5.49K | $ 43.39K | $ 150.00K | $ 50.00K | $ 380.50K |
Currency in USD
